B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Clinical trials for B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) explained in plain language.
Never miss a new study
Get alerted when new B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) trials appear
Sign up with your email to follow new studies for B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cell therapy JY231 targets tough leukemia in early human test
Disease control Recruiting nowThis early study is testing a new treatment called JY231 for people with B-cell acute lymphoblastic leukemia (B-ALL), a type of blood cancer. The main goal is to check if JY231 is safe and tolerable, and to see if it can help control the disease. About 20 adults and children up t…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Phase: EARLY_PHASE1 • Sponsor: 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
Experimental injection targets tough blood cancers and anemia
Disease control Recruiting nowThis early-phase study tests a new treatment called GT801 in 28 adults with certain blood cancers (like leukemia and lymphoma) or an autoimmune condition that destroys red blood cells. The goal is to see if the injection is safe and can shrink tumors or control the autoimmune dis…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Phase: EARLY_PHASE1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC
-
New hope for tough leukemia: experimental drug AZD4512 enters human testing
Disease control Recruiting nowThis study is for people with B-cell acute lymphoblastic leukemia (B-ALL) that has returned or not responded to standard treatments. Researchers are testing a new drug called AZD4512, given alone or with other cancer drugs, to see if it is safe and can help shrink or control the …
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
New CAR T-Cell production method could improve leukemia treatment for kids
Disease control Recruiting nowThis study is for children with B-cell acute lymphoblastic leukemia (B-ALL) that has come back or not responded to standard treatments. Researchers are testing a new way to make special immune cells (CAR T-cells) that can find and kill cancer cells. The goal is to see if this new…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Phase: PHASE1, PHASE2 • Sponsor: Stephan Grupp MD PhD • Aim: Disease control
Last updated Jun 11, 2026 11:57 UTC
-
New hope for relapsed leukemia patients?
Disease control Recruiting nowThis study tests a new drug, AZD0486, in teens and adults whose B-cell acute lymphoblastic leukemia (B-ALL) has come back or not responded to at least two prior treatments. The goal is to see if the drug is safe and can shrink or eliminate cancer cells. Because participants may n…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 08, 2026 13:08 UTC
-
CAR T-Cell survivors: what happens years later?
Knowledge-focused Recruiting nowThis study looks at the long-term health and quality of life of children, teens, and young adults who received CAR T-cell therapy for B-cell acute lymphoblastic leukemia (B-ALL) at least two years ago. Researchers want to see if it's possible to regularly check for late side effe…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:53 UTC
-
Leukemia treatment may weaken vaccine protection – study seeks answers
Knowledge-focused Recruiting nowThis study looks at whether children and young adults (up to age 21) who received blinatumomab for B-cell acute lymphoblastic leukemia still have protection from their routine childhood vaccines. Researchers will test antibody levels for diseases like tetanus, hepatitis B, and me…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Sponsor: Arkansas Children's Hospital Research Institute • Aim: Knowledge-focused
Last updated Jun 09, 2026 12:06 UTC